A continuing decline in sales of COVID-19 products clips revenue at Pfizer
Pfizer losses were not as great as expected in the third quarter, but a continued decline in sales of its COVID-19 products clipped revenue.
Pfizer Inc. on Tuesday reported a $2.38 billion quarterly loss, or 42 cents per share. Adjusted for one-time gains or losses, the New York company lost 17 cents per share, a much narrower loss than the 42 cents that Wall Street had expected, according to a survey of industry analysts by FactSet.
The company expects lower revenue overall this year due to…